Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Efflux Pump Inhibitors
100%
Antimycobacterial Activity
100%
C6 Position
100%
C7 Position
100%
Mycobacterium Avium
71%
Inhibitor Activity
42%
Clarithromycin
28%
Toxicity Issues
28%
Computational Approach
14%
Therapeutic Potential
14%
Microbes
14%
Efflux Pump
14%
Analogue Compound
14%
Medicinal Chemistry
14%
Design Evaluation
14%
Ready-to-use
14%
Mycobacterium
14%
Human Cells
14%
Biological Evaluation
14%
Infected Macrophages
14%
Intracellular Infection
14%
Synthetic Evaluation
14%
Human Macrophages
14%
Cystic Fibrosis
14%
Ex Vivo Model
14%
Pulmonary Disease
14%
FDA-approved Drugs
14%
New Scaffolds
14%
Pharmacophore Model
14%
Nicardipine
14%
CC50
14%
Pharmacology, Toxicology and Pharmaceutical Science
Effusion
100%
Atypical Mycobacterium
100%
Antimycobacterial Agent
100%
Clarithromycin
28%
Pharmaceutical Chemistry
14%
Infection
14%
Infectious Agent
14%
Mycobacteria
14%
Lung Disease
14%
Cystic Fibrosis
14%
Nicardipine
14%